EUVIMEDEUVIMED entdecken
Crossref

Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis

Saima Ahmed Remi, Ishrat Bhuiyan, Md Shahadat Hossain, Mohammad Niamat Alahi, Md Motiul Hossain, Shiropa Islam

Journal of Shaheed Suhrawardy Medical College · 15.03.2026 · 16 (2) · 7-15

DOI: 10.3329/jssmc.v16i2.88262 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Shaheed Suhrawardy Medical College, online erschienen am 15.03.2026. Verfasst von Saima Ahmed Remi und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atopic dermatitis is a common chronic inflammatory skin condition. It affects upto 20% of children and 3% of atopic dermatitisults; most of them are mild to moderate in severity. There are onle a few effective topical therapeutic options available for long term use. This study was aimed to evaluate the efficacy and safety of Crisaborole ointment (2%), a new non-steroidal topical anti-inflammatory phosphodiesterase-4 (PDE4) inhibitor for the treatment of mild to moderate Atopic dermatitis.

Methods

This prospective clinical trial was conducted at the Department of Dermatology & Venereology in Shaheed Suhrawardy Medical College Hospital, Dhaka, for a period of 12-months following approval of this protocol. A total of 226 patients with Mild to moderate Atopic dermatitis were included after getting informed written consent and divided into two equal groups: Crisaborole 2% ointment and placebo. Patients were followed up at 4 th, 8th and 12th weeks of intervention. However, 20 patients were lost in this trial period, and finally 103 patients in each group were analyzed as per-protocol analysis. Data were analyzed by the SPSS 26.

Results

Demographic characteristics were similar across the two groups in terms of age and gender (p>0.05 in all cases). No significant difference was noted in age of onset, family history, personal history, precipitating factors and pre-operative ISGA score (p>0.05). Mean ISGA score of Crisaborole 2% ointment atopic dermatitis significantly decreased from baseline to 12th week follow up (2.32 vs 0.89, p

Zitieren

APA

Remi, S. A., Bhuiyan, I., Hossain, M. S., Alahi, M. N., Hossain, M. M., & Islam, S. (2026). Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis. Journal of Shaheed Suhrawardy Medical College, 16(2), 7-15. https://doi.org/10.3329/jssmc.v16i2.88262

Vancouver

Remi SA, Bhuiyan I, Hossain MS, Alahi MN, Hossain MM, Islam S. Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis. Journal of Shaheed Suhrawardy Medical College. 2026;16(2):7-15. doi:10.3329/jssmc.v16i2.88262

BibTeX
@article{Remi2026,
  author = {Remi, Saima Ahmed and Bhuiyan, Ishrat and Hossain, Md Shahadat and Alahi, Mohammad Niamat and Hossain, Md Motiul and Islam, Shiropa},
  title = {Efficacy and Safety of Crisaborole Ointment 2% in Mild to Moderate Atopic dermatitis},
  journal = {Journal of Shaheed Suhrawardy Medical College},
  year = {2026},
  volume = {16},
  number = {2},
  pages = {7--15},
  doi = {10.3329/jssmc.v16i2.88262}
}
Kostenlos starten →